Dose-dependent effects and specificity of action of antibodies to endogenous regulators in ultralow doses

Bulletin of Experimental Biology and Medicine

Volumn 137, Issue 5, 2004, Pages 460-462

  Epstein, O I ^a,b   Sherstoboev, E Yu ^a,b   Martyushev Poklad, A V ^a,b   Dugina, Yu L ^a,b   Sergeeva, S A ^a,b   Dygai, A M ^a,b  

^a INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^b Materia Medica Holding Research and Production Company   (Russian Federation)

Author keywords

Antibodies against interferon , erythropoietin, and tumor necrosis factor ; Interferon ; Ultralow doses

Indexed keywords

CYTOKINE ANTIBODY; ERYTHROPOIETIN; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG SPECIFICITY; EXPERIMENTAL MODEL; LOW DRUG DOSE; LYMPHOCYTE; MALE; MOUSE; NONHUMAN; PROTEIN SYNTHESIS;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROPOIETIN; INTERFERON TYPE II; LYMPHOCYTES; MALE; MICE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 4344667281     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BEBM.0000038153.60142.84     Document Type: Article

References (12)

1. I. P. Ashmarin and I. S. Freidlin, Zh. Evolyuts. Biokhim. Fiziol., 25, No. 2, 176-182 (1989).
2. E. B. Burlakova, A. A. Konradov, and I. B. Khudyakov, Izv. Akad. Nauk SSSR, No. 2, 184-194 (1990).
3. E. D. Gol'dberg, A. M. Dygai, and V. P. Shakhov, Tissue Culture Methods in Hematology [in Russian], Tomsk (1992).
4. V. G. Zilov, K. V. Sudakov, and O. I. Epstein, Elements of Informational Biology and Medicine [in Russian], Moscow (2000).
5. N. P. Kravkov, Usp. Eksper. Biol., Nos. 3-4, 147-172 (1924).
6. A. B. Poletaev, S. G. Morozov, and I. E. Kovalev, Regulatory Metasystem (Immunoneuroendocrine Regulation of Homeostasis) [in Russian], Moscow (2002).
7. E. Yu. Sherstoboev, N. V. Masnaya, A. A. Churin, et al., Byull. Eksp. Biol. Med., Suppl. 4, 79-82 (2002).
8. O. I. Epstein, N. A. Beregovoi, T. M. Pankova, et al., Ibid., Suppl. 1, 20-23 (2003).
9. E. Davenas, F. Beauvais, J. Amara, et al., Nature, 333, No. 6176, 816-818 (1988).
10. G. Harisch and J. Dittmann, Biomedical Therapy, 15, No. 2, 40-46 (1997).
11. S. Raga, M. R. Julia, C. Crespi, et al., Respir. Res., 4, No. 1, 9 (2003).
12. D. R. Wesemann and E. N. Benveniste, J. Immunol., 171, No. 10, 5313-5319 (2003).